Related Experiment Video
Updated: May 25, 2026
09:16
Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
Sequential array comparative genomic hybridization analysis identifies copy number changes during blastic
Seung-Tae Lee1, Yongick Ji, Hee-Jin Kim
1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Leukemia Research
|February 8, 2012
Summary
This study reveals genomic alterations during chronic myeloid leukemia (CML) progression to blastic phase (BP). Key findings include copy number losses and a novel fusion gene, suggesting a multi-step process in blastic transformation.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the Philadelphia chromosome.
- Progression from chronic phase (CP) to blastic phase (BP) involves significant genetic changes.
- Understanding these genomic events is crucial for targeted therapies.
Purpose of the Study:
- To investigate copy number changes during CML progression from CP to BP.
- To identify specific genomic alterations associated with blastic transformation.
- To provide direct evidence of genomic instability in CML progression.
Main Methods:
- Longitudinal follow-up study design.
- Analysis of matched CP and BP samples from three CML patients.
- High-resolution array comparative genomic hybridization (aCGH) for detecting copy number variations.
Main Results:
- Observed loss of large genomic segments, including 6q14.1-q22.31 and chromosome 7.
- Identified copy number changes in cancer-associated genes.
- Discovered a novel fusion gene involving PAX5 and MLLT3 (AF9).
Conclusions:
- Blastic transformation in CML is a multi-step process.
- Genomic events during blastic transformation overlap with those in acute leukemias.
- Accumulation of genomic alterations drives CML progression to blastic phase.
